{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:19:29Z","timestamp":1791523169833,"version":"4.3.4"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T00:00:00Z","timestamp":1470614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0160462","type":"journal-article","created":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T17:40:08Z","timestamp":1470678008000},"page":"e0160462","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mice Expressing a \"Hyper-Sensitive\" Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor Diabetic"],"prefix":"10.1371","volume":"11","author":[{"given":"David J.","family":"Marcus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Zee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris P.","family":"Haskins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Jeanette","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela N.","family":"Henderson-Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci A.","family":"Czyzyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,8,8]]},"reference":[{"key":"ref1","first-page":"1","article-title":"Deaths: preliminary data for 2011","volume":"61","author":"DL Hoyert","year":"2012","journal-title":"Natl Vital Stat Rep"},{"issue":"Suppl 3","key":"ref2","first-page":"120","article-title":"Obesity\u2014United States, 1999\u20132010","volume":"62","author":"AL May","year":"2013","journal-title":"MMWR Surveill Summ"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"w822","DOI":"10.1377\/hlthaff.28.5.w822","article-title":"Annual medical spending attributable to obesity: payer-and service-specific estimates","volume":"28","author":"EA Finkelstein","year":"2009","journal-title":"Health Aff (Millwood)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/sj.ijo.0802583","article-title":"CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity","volume":"28","author":"C Ravinet Trillou","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","article-title":"The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis","volume":"112","author":"D Cota","year":"2003","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"R345","DOI":"10.1152\/ajpregu.00545.2002","article-title":"Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice","volume":"284","author":"C Ravinet Trillou","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pbb.2006.06.001","article-title":"The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake","volume":"84","author":"ZD Thornton-Jones","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.21641","article-title":"Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa\/fa rats","volume":"46","author":"M Gary-Bobo","year":"2007","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.2337\/db08-0161","article-title":"Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats","volume":"57","author":"R Nogueiras","year":"2008","journal-title":"Diabetes"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1210\/en.2007-1515","article-title":"Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats","volume":"149","author":"AW Herling","year":"2008","journal-title":"Endocrinology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/ijo.2008.3","article-title":"Effects of rimonabant, a cannabinoid CB1 receptor ligand, on energy expenditure in lean rats","volume":"32","author":"I Kunz","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0091-3057(01)00467-1","article-title":"Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets","volume":"68","author":"JE Koch","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0091-3057(01)00694-3","article-title":"Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine","volume":"71","author":"CM Williams","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bjp.0706157","article-title":"CB1 cannabinoid receptor-mediated modulation of food intake in mice","volume":"145","author":"JL Wiley","year":"2005","journal-title":"Br J Pharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2005-2679","article-title":"Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia","volume":"91","author":"I Matias","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1007\/s00125-011-2274-6","article-title":"Altered endocannabinoid signalling after a high-fat diet in Apoe(-\/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance","volume":"54","author":"A Bartelt","year":"2011","journal-title":"Diabetologia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"E2229","DOI":"10.1073\/pnas.1219485110","article-title":"Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons","volume":"110","author":"L Cristino","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bph.12013","article-title":"A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects","volume":"169","author":"T Bisogno","year":"2013","journal-title":"Br J Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"14561","DOI":"10.1073\/pnas.0807232105","article-title":"Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins","volume":"105","author":"MA Ruby","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuropharm.2007.06.005","article-title":"Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1\/2 MAP kinase signaling","volume":"54","author":"TL Daigle","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1471-4159.2008.05336.x","article-title":"Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism","volume":"106","author":"TL Daigle","year":"2008","journal-title":"J Neurochem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1523\/JNEUROSCI.19-10-03773.1999","article-title":"Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization","volume":"19","author":"W Jin","year":"1999","journal-title":"J Neurosci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1471-4159.1999.0730493.x","article-title":"Internalization and recycling of the CB1 cannabinoid receptor","volume":"73","author":"C Hsieh","year":"1999","journal-title":"J Neurochem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1523\/JNEUROSCI.3445-12.2014","article-title":"Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice","volume":"34","author":"DJ Morgan","year":"2014","journal-title":"J Neurosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"20270","DOI":"10.1073\/pnas.0909411106","article-title":"Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo","volume":"106","author":"JZ Long","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1079\/095442201108729141","article-title":"Endogenous cannabinoids and appetite","volume":"14","author":"TC Kirkham","year":"2001","journal-title":"Nutr Res Rev"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00024677-200403060-00003","article-title":"Endocannabinoid receptor antagonists: potential for obesity treatment","volume":"3","author":"TC Kirkham","year":"2004","journal-title":"Treat Endocrinol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050953","article-title":"Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors","volume":"143","author":"CM Williams","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0031-9384(98)00170-X","article-title":"Hyperphagia in pre-fed rats following oral delta9-THC","volume":"65","author":"CM Williams","year":"1998","journal-title":"Physiol Behav"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-2999(00)00059-5","article-title":"Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice","volume":"392","author":"S Hao","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"ref31","first-page":"13","article-title":"Management of anorexia-cachexia associated with cancer and HIV infection","volume":"5","author":"R Gorter","year":"1991","journal-title":"Oncology (Williston Park)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00002030-199201000-00018","article-title":"Dronabinol effects on weight in patients with HIV infection","volume":"6","author":"R Gorter","year":"1992","journal-title":"AIDS"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJM197510162931603","article-title":"Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy","volume":"293","author":"SE Sallan","year":"1975","journal-title":"N Engl J Med"},{"key":"ref34","first-page":"179","article-title":"SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset","volume":"9","author":"J Simiand","year":"1998","journal-title":"Behav Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/mol.105.015040","article-title":"The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes","volume":"69","author":"M Gary-Bobo","year":"2006","journal-title":"Mol Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/oby.2009.84","article-title":"Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism","volume":"17","author":"D Cota","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"JP Despres","year":"2005","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","article-title":"Activation of the peripheral endocannabinoid system in human obesity","volume":"54","author":"S Engeli","year":"2005","journal-title":"Diabetes"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1210\/en.2011-1423","article-title":"Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db\/db mice","volume":"153","author":"DH Nam","year":"2012","journal-title":"Endocrinology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejphar.2005.12.016","article-title":"Activation of cannabinoid CB1 receptors induces glucose intolerance in rats","volume":"531","author":"FJ Bermudez-Siva","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuropharm.2013.09.019","article-title":"DeltaFosB induction correlates inversely with CB(1) receptor desensitization in a brain region-dependent manner following repeated Delta(9)-THC administration","volume":"77","author":"MF Lazenka","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biopsych.2011.11.027","article-title":"beta-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner","volume":"71","author":"PT Nguyen","year":"2012","journal-title":"Biol Psychiatry"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1124\/jpet.107.130328","article-title":"Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol","volume":"324","author":"DL McKinney","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0169-328X(98)00232-0","article-title":"Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions","volume":"62","author":"S Zhuang","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1476-5381.2010.00870.x","article-title":"Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposure","volume":"161","author":"JJ Burston","year":"2010","journal-title":"Br J Pharmacol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/sj.bjp.0707313","article-title":"Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus","volume":"151","author":"E Soria-Gomez","year":"2007","journal-title":"Br J Pharmacol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bmcl.2008.12.059","article-title":"Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice","volume":"19","author":"J LoVerme","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1172\/JCI42551","article-title":"Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity","volume":"120","author":"J Tam","year":"2010","journal-title":"J Clin Invest"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/dom.12646","article-title":"Endocannabinoid regulation of beta-cell functions: implications for glycaemic control and diabetes","volume":"18","author":"T Jourdan","year":"2016","journal-title":"Diabetes Obes Metab"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0160462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:40:21Z","timestamp":1589024421000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0160462"}},"subtitle":[],"editor":[{"given":"Daniela","family":"Cota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,8]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0160462","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,8]]}}}